Analgesic Use and Sex Steroid Hormone Concentrations in Postmenopausal Women
Open Access
- 1 April 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (4), 1033-1041
- https://doi.org/10.1158/1055-9965.epi-09-0975
Abstract
Prior epidemiologic studies suggest that regular use of analgesics may decrease risk of breast and ovarian cancer. We explored possible hormone-mediated mechanisms for these associations by examining the relationship between use of aspirin, nonaspirin nonsteroidal anti-inflammatory drugs (NSAID), and acetaminophen and sex steroid hormone concentrations among 740 postmenopausal women in the Nurses' Health Study. All women reported their analgesic use in 1988 or 1990 and provided a blood sample in 1989 to 1990. We calculated adjusted geometric mean estrogen and androgen levels for each category of analgesic use and calculated the P value for trend with increasing frequency of use. There was no association between days of use per month of aspirin, nonaspirin NSAIDs, or acetaminophen in 1990 and hormone levels (all Ptrend ≥ 0.09). However, we observed significant inverse trends between the estimated number of aspirin tablets per month in 1988 and concentrations of estrone (Ptrend = 0.04) and estrone sulfate (Ptrend = 0.03). In analyses of total (aspirin and nonaspirin) NSAID use in 1990, women who used NSAIDs at least 15 days per month had significantly lower levels of estradiol compared with women with no NSAID use (Ptrend = 0.03). Frequency of use of all analgesics (aspirin, nonaspirin NSAIDs, and acetaminophen) in 1990 was inversely associated with concentrations of estradiol (Ptrend = 0.001), free estradiol (Ptrend = 0.01), estrone sulfate (Ptrend = 0.03), and the ratio of estradiol to testosterone (Ptrend = 0.04). Among postmenopausal women, regular users of aspirin and other analgesics may have lower estrogen levels than nonusers, which could contribute to a decreased risk of breast or ovarian cancer among analgesic users. Cancer Epidemiol Biomarkers Prev; 19(4); 1033–41. ©2010 AACR.Keywords
Other Versions
This publication has 55 references indexed in Scilit:
- Risk Factors for Epithelial Ovarian Cancer by Histologic SubtypeAmerican Journal of Epidemiology, 2009
- Use of Nonsteroidal Antiinflammatory Agents and Incidence of Ovarian Cancer in 2 Large Prospective CohortsAmerican Journal of Epidemiology, 2009
- Use of Aspirin, Other Nonsteroidal Anti-inflammatory Drugs, and Acetaminophen and Risk of Breast Cancer Among Premenopausal Women in the Nurses' Health Study IIJAMA Internal Medicine, 2009
- Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancerCancer Causes & Control, 2008
- Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parityBritish Journal of Cancer, 2008
- Aspirin use and breast cancer risk: a meta‐analysis and meta‐regression of observational studies from 2001 to 2005Pharmacoepidemiology and Drug Safety, 2008
- Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal womenBreast Cancer Research and Treatment, 2007
- A prospective study of postmenopausal hormone use and ovarian cancer riskBritish Journal of Cancer, 2006
- Paracetamol use and risk of ovarian cancer: a meta‐analysisBritish Journal of Clinical Pharmacology, 2005
- Breast cancer and NSAID use: a meta-analysisBritish Journal of Cancer, 2001